Literature DB >> 32003793

Absence of the type I-E CRISPR-Cas system in Klebsiella pneumoniae clonal complex 258 is associated with dissemination of IncF epidemic resistance plasmids in this clonal complex.

Yu Tang1,2, Pan Fu2, Ying Zhou2, Yingzhou Xie3, Jialin Jin4, Bei Wang2, Lianhua Yu5, Yunkun Huang6, Gang Li7, Meng Li8, Wei Liang9, Hong-Yu Ou3, Xiaofei Jiang2.   

Abstract

BACKGROUND: The pandemics caused by MDR Klebsiella pneumoniae are mostly due to the global dissemination of high-risk clonal complex 258 (CC258) and related IncF epidemic plasmids. However, the factors leading to the epidemiological advantages of CC258-IncF linkage remain obscure. The Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) and CRISPR-associated protein (CRISPR-Cas) systems, providing adaptive immunity against invading DNA, play an important role in the interactions between plasmids and hosts.
OBJECTIVES: To investigate the relationship between CRISPR-Cas systems and the high-risk linkage CC258-IncF.
METHODS: CRISPR-Cas loci were detected among 381 collected K. pneumoniae clinical isolates and 207 K. pneumoniae complete genomes available in GenBank. MLST was used to determine the genetic relatedness of these isolates. Nucleotide BLAST was used to search for protospacers on K. pneumoniae plasmids.
RESULTS: We observed an epidemic correlation between CRISPR-Cas loci, CC258 and IncF plasmids. Interestingly, most type I-E CRISPR-Cas systems identified carried spacers matching the backbone regions of IncF plasmids.
CONCLUSIONS: Our results suggest that the absence of type I-E CRISPR-Cas systems in K. pneumoniae CC258 is strongly associated with the dissemination of IncF epidemic plasmids, contributing to the global success of the international high-risk linkage CC258-IncF. Our findings provide new information regarding the dissemination and evolution of the high-risk linkage of K. pneumoniae CC258-IncF and pave the way for new strategies to address the problem of antibiotic resistance.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2020        PMID: 32003793     DOI: 10.1093/jac/dkz538

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Epidemiology of Plasmids in Escherichia coli and Klebsiella pneumoniae with Acquired Extended Spectrum Beta-Lactamase Genes Isolated from Chronic Wounds in Ghana.

Authors:  Frederik Pankok; Stefan Taudien; Denise Dekker; Thorsten Thye; Kwabena Oppong; Charity Wiafe Akenten; Maike Lamshöft; Anna Jaeger; Martin Kaase; Simone Scheithauer; Konstantin Tanida; Hagen Frickmann; Jürgen May; Ulrike Loderstädt
Journal:  Antibiotics (Basel)       Date:  2022-05-19

2.  Association of CRISPR/Cas System with the Drug Resistance in Klebsiella pneumoniae.

Authors:  Gang Wang; Guobin Song; Yuanhong Xu
Journal:  Infect Drug Resist       Date:  2020-06-23       Impact factor: 4.003

3.  Genetic determinants facilitating the evolution of resistance to carbapenem antibiotics.

Authors:  Peijun Ma; Lorrie L He; Alejandro Pironti; Hannah H Laibinis; Christoph M Ernst; Abigail L Manson; Roby P Bhattacharyya; Ashlee M Earl; Jonathan Livny; Deborah T Hung
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

4.  Phylogenetic Distribution of CRISPR-Cas Systems in Staphylococcus lugdunensis.

Authors:  Cheng-Yen Kao; Jang-Jih Lu; Lee-Chung Lin; Hsiao-Chi Lin; Shih-Cheng Chang
Journal:  Microbiol Spectr       Date:  2021-12-01

5.  Genomic evolution of the globally disseminated multidrug-resistant Klebsiella pneumoniae clonal group 147.

Authors:  Carla Rodrigues; Siddhi Desai; Virginie Passet; Devarshi Gajjar; Sylvain Brisse
Journal:  Microb Genom       Date:  2022-01

6.  IncFIB-4.1 and IncFIB-4.2 Single-Replicon Plasmids: Small Backbones with Large Accessory Regions.

Authors:  Yanan Xu; Ying Jing; Lingfei Hu; Qiaoxiang Cheng; Huixia Gao; Zhi Zhang; Huiying Yang; Yuee Zhao; Dongsheng Zhou; Zhe Yin; Erhei Dai
Journal:  Infect Drug Resist       Date:  2022-03-22       Impact factor: 4.003

7.  The Role of Plasmid and Resistance Gene Acquisition in the Emergence of ST23 Multi-Drug Resistant, Hypervirulent Klebsiella pneumoniae.

Authors:  Pengcheng Du; Chao Liu; Shuaihua Fan; Stephen Baker; Jun Guo
Journal:  Microbiol Spectr       Date:  2022-03-17

8.  Molecular Characteristics of Escherichia coli Causing Bloodstream Infections During 2010-2015 in a Tertiary Hospital, Shanghai, China.

Authors:  Dan Li; Pei Li; Xiaoyan Yu; Xuefei Zhang; Qinglan Guo; Xiaogang Xu; Minggui Wang; Minghua Wang
Journal:  Infect Drug Resist       Date:  2021-06-03       Impact factor: 4.003

9.  The type I-E CRISPR-Cas system influences the acquisition of blaKPC-IncF plasmid in Klebsiella pneumonia.

Authors:  Ying Zhou; Yu Tang; Pan Fu; Dongxing Tian; Lianhua Yu; Yunkun Huang; Gang Li; Meng Li; Yong Wang; Zehua Yang; Xiaogang Xu; Zhe Yin; Dongsheng Zhou; Laurent Poirel; Xiaofei Jiang
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

10.  Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital.

Authors:  Julian Schwanbeck; Wolfgang Bohne; Ufuk Hasdemir; Uwe Groß; Yvonne Pfeifer; Boyke Bunk; Thomas Riedel; Cathrin Spröer; Jörg Overmann; Hagen Frickmann; Andreas E Zautner
Journal:  Microorganisms       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.